Furin is an enzyme that acts like a molecular pair of scissors inside your cells, cutting inactive proteins into their active forms. It sits primarily in a cellular compartment called the trans-Golgi network, a sorting and processing hub, and snips precursor proteins at specific sites so they can do their jobs. Nearly every tissue in the body produces furin, including the brain, liver, gut, and lungs. It gained widespread attention during the COVID-19 pandemic because SARS-CoV-2 exploits furin to help the virus enter human cells, but its normal role is far broader: furin activates growth factors, hormones, receptors, and neuropeptides that keep the body functioning.
How Furin Works Inside Cells
Furin belongs to a family of enzymes called proprotein convertases. Many important proteins start out as larger, inactive precursors. Furin recognizes a specific pattern of amino acids on these precursors, a short stretch rich in the positively charged building blocks arginine and lysine, and cuts them at that spot. This single cut can transform a dormant molecule into one that signals growth, shapes tissue development, or regulates the immune system.
The enzyme is anchored in cell membranes and doesn’t stay in one place. At any given moment, most furin molecules sit in the trans-Golgi network, but they constantly shuttle between that hub, the cell surface, and deeper sorting compartments called endosomes. This cycling means furin can intercept and process proteins at multiple points along the cell’s internal shipping routes. The balance between how quickly it reaches the surface and how quickly it returns keeps the majority of furin concentrated where newly made proteins are being packaged and sent out.
Proteins That Depend on Furin
The list of proteins furin activates is long and spans nearly every major signaling system in the body. One of its best-studied jobs is converting the precursor of transforming growth factor beta-1 (TGF-β1) into its mature form. TGF-β1 is a powerful regulator of cell growth and differentiation, and research has confirmed that furin is the predominant enzyme responsible for this conversion. Furin also processes bone morphogenetic proteins, which guide bone and cartilage formation, as well as signaling molecules like nodal that help establish left-right body symmetry during embryonic development.
Beyond growth factors, furin activates the insulin receptor, which cells need to respond to insulin and regulate blood sugar. It processes the Notch1 receptor, a key player in cell fate decisions during development and tissue maintenance. It also clips several metalloproteinases, enzymes that remodel the structural scaffolding between cells. In short, without furin, many of the body’s communication and construction systems would stall at the precursor stage.
Why Viruses and Bacteria Exploit Furin
The same cutting ability that activates normal human proteins makes furin a target for pathogens. Many viruses coat themselves in surface proteins that need to be cleaved before they can fuse with a host cell membrane. If a virus evolves a furin-recognition site into its surface protein, it can hijack the host’s own furin to prime itself for infection, often during the packaging stage before the virus even leaves the producing cell.
HIV uses furin to process its envelope glycoprotein gp160 into the pieces that latch onto immune cells. Ebola and Marburg viruses rely on furin-like cleavage for their fusion machinery. Influenza A H5N1 (bird flu) carries a furin site in its hemagglutinin protein, a feature linked to higher virulence. Bacterial toxins from anthrax and botulinum similarly require furin processing to become fully toxic. MERS-CoV, the coronavirus behind Middle East respiratory syndrome, was the first naturally occurring coronavirus known to have furin cleavage sites at two separate locations on its spike protein.
Furin and SARS-CoV-2
SARS-CoV-2 drew global attention to furin because its spike protein contains a distinctive insertion of amino acids (PRRAR) at the junction between two functional regions called S1 and S2. This polybasic insertion allows furin to cut the spike protein while the virus is still being assembled inside an infected cell, pre-arming it for entry into the next target. The original SARS-CoV from 2003 lacked this furin site, which is one reason the two viruses behave so differently.
Experiments published in Nature Microbiology showed that the furin cleavage site gives SARS-CoV-2 a clear advantage in lung cells and human airway tissue. When researchers deleted this site, the modified virus replicated to lower levels in ferrets and, critically, failed to transmit to animals housed alongside infected ones. Wild-type virus with the intact furin site transmitted readily. This made the furin cleavage site one of the most important molecular features shaping the pandemic’s spread.
Entry into a cell actually requires two cuts on the spike protein, not just one. After furin cleaves the S1/S2 junction, a second site called S2′ becomes exposed. That second cut can be made by other enzymes at the cell surface or inside endosomes, triggering the final membrane fusion step that lets the virus inject its genetic material.
Furin’s Role in Cancer
Because furin activates growth factors, receptors, and tissue-remodeling enzymes, its overproduction can tip the balance toward uncontrolled cell growth. Abnormally high furin levels have been documented in breast, lung, ovarian, and liver cancers, as well as head and neck squamous cell carcinoma, sarcoma, and papillary thyroid carcinoma.
Colorectal cancer provides one of the more detailed pictures. A study of over 1,100 colorectal cancer cases found furin overexpression in nearly 47% of tumors, and that overexpression correlated with activation of signaling pathways that drive cell proliferation. In lab models, forcing cells to produce extra furin increased their growth rate and their ability to form colonies, while silencing furin slowed tumor growth and made cancer cells more responsive to chemotherapy. In animal models, tumors with high furin grew faster, and depleting furin markedly shrank them. Previous work from the same group showed that furin upregulation also promoted the spread of papillary thyroid carcinoma.
These findings have made furin an appealing therapeutic target. In several cancer models, blocking furin either genetically or with experimental compounds reduced both tumor growth and metastasis.
Furin Inhibitors as Potential Therapies
Researchers have been developing molecules designed to block furin’s active site, preventing it from cutting its targets. The most widely used laboratory inhibitor is a compound called Dec-RVKR-CMK, which binds directly to furin’s catalytic pocket and permanently inactivates it. This compound has been instrumental in proving furin’s role in disease models, but it is a research tool rather than a drug.
The challenge with furin inhibitors is specificity. Furin processes so many essential proteins that broadly shutting it down could cause serious side effects. Drug development efforts are focused on designing inhibitors selective enough to reduce furin activity in diseased tissues (a tumor, for instance, or virus-infected airway cells) without disrupting its housekeeping roles elsewhere. As of now, no furin inhibitor has reached routine clinical use, but the enzyme remains one of the more actively studied drug targets in both oncology and infectious disease.
Where the Name Comes From
Furin was identified in 1990 and gets its name from the stretch of DNA where its gene was originally found. The gene sat in a region called FUR, short for “FES/FPS upstream region,” located next to a known cancer-related gene called fes/fps. Researchers recognized that this gene encoded the first mammalian version of an enzyme previously known only in yeast, where a related protein called Kex2 processes precursor proteins in much the same way. Shortly after its discovery, furin was shown to correctly process precursors for nerve growth factors, blood serum proteins, and pathogen molecules, establishing it as a central player in protein maturation across the body.